Abstract
Endogenous opioid peptides have been implicated in the genesis and maintenance of self-injurious behavior. This paper presents an overview of the basic pharmacology of opioid peptides and opioid antagonists and briefly outlines the rationale for using these agents to treat self-injury in individuals with mental retardation. The basic assumption is that self-injury is related to the endogenous opioid system, with two, nonexclusive mechanisms having been postulated that may account for this behavior.
Original language | English (US) |
---|---|
Pages (from-to) | 5-15 |
Number of pages | 11 |
Journal | Journal of Developmental and Physical Disabilities |
Volume | 5 |
Issue number | 1 |
DOIs | |
State | Published - Mar 1993 |
Externally published | Yes |
Keywords
- opioid antagonists
- pharmacology
- self-injury
ASJC Scopus subject areas
- Physical Therapy, Sports Therapy and Rehabilitation
- Developmental and Educational Psychology